Les nouvelles modalités d’inhibition du système rénine angiotensine : les inhibiteurs de la rénine et l’immunisation active contre l’angiotensine II

H Urata, A Kinoshita, K S Misono, F M Bumpus, A Husain, Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. Journal of Biological Chemistry. ,vol. 265, pp. 22348- 22357 ,(1990) , 10.1016/S0021-9258(18)45712-2

Joël Ménard, A vaccine for hypertension. Journal of Hypertension. ,vol. 25, pp. 41- 46 ,(2007) , 10.1097/HJH.0B013E328012981B

Thong Huy Do, Yijia Chen, Van T Nguyen, Sorot Phisitkul, None, Vaccines in the management of hypertension Expert Opinion on Biological Therapy. ,vol. 10, pp. 1077- 1087 ,(2010) , 10.1517/14712598.2010.487060

Michel Azizi, Randy Webb, Juerg Nussberger, Norman K Hollenberg, Renin inhibition with aliskiren: where are we now, and where are we going? Journal of Hypertension. ,vol. 24, pp. 243- 256 ,(2006) , 10.1097/01.HJH.0000202812.72341.99

Jean-Baptiste MICHEL, Renin-angiotensin vaccine: old story, new project 'efficacy versus safety'. Clinical Science. ,vol. 107, pp. 145- 147 ,(2004) , 10.1042/CS20040116

Pieter F. Vos, Peter Boer, Branko Braam, Hein A. Koomans, Efficacy of intrarenal ACE-inhibition estimated from the renal response to angiotensin I and II in humans Kidney International. ,vol. 47, pp. 274- 281 ,(1995) , 10.1038/KI.1995.35

Patrice M Ambühl, Alain C Tissot, Alma Fulurija, Patrik Maurer, Juerg Nussberger, Robert Sabat, Vera Nief, Charlotte Schellekens, Katja Sladko, Kirsten Roubicek, Thomas Pfister, Manfred Rettenbacher, Hans-Dieter Volk, Frank Wagner, Philipp Müller, Gary T Jennings, Martin F Bachmann, A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. Journal of Hypertension. ,vol. 25, pp. 63- 72 ,(2007) , 10.1097/HJH.0B013E32800FF5D6

Roland E. Schmieder, Thomas Philipp, Javier Guerediaga, Manuel Gorostidi, Beverly Smith, Nicole Weissbach, Mojdeh Maboudian, Jaco Botha, Hein van Ingen, Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide. Circulation. ,vol. 119, pp. 417- 425 ,(2009) , 10.1161/CIRCULATIONAHA.107.750745

V M Musini, P M Fortin, K Bassett, J M Wright, Blood pressure lowering efficacy of renin inhibitors for primary hypertension: a Cochrane systematic review Journal of Human Hypertension. ,vol. 23, pp. 495- 502 ,(2009) , 10.1038/JHH.2008.162

J B Michel, S Sayah, C Guettier, J Nussberger, M Philippe, M F Gonzalez, C Carelli, F X Galen, J Menard, P Corvol, Physiological and immunopathological consequences of active immunization of spontaneously hypertensive and normotensive rats against murine renin. Circulation. ,vol. 81, pp. 1899- 1910 ,(1990) , 10.1161/01.CIR.81.6.1899